However, Fos was the third most highly upregulated FoxO target gene in response to C26 (16-fold), which is in alignment with a previous microarray study showing upregulation of Fos in muscles from both moderately and severely cachectic C26 tumor-bearing mice [12]. The gene discussed is FOS; the disease is neoplasm.